Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 0 | 911 | 0 | 0 | 79 |
| Gross Profit | N/A | 911 | 0 | N/A | 79 |
| Operating Expenses | 9,633 | 23,236 | 22,315 | 11,773 | 13,405 |
| Operating Income | -9,633 | -22,325 | -22,315 | -11,773 | -13,326 |
| Other Income | 331 | 90 | 155 | 176 | 172 |
| Pre-tax Income | -9,302 | -22,235 | -22,160 | -11,597 | -13,154 |
| Income Tax | -2 | -31 | -189 | -55 | -79 |
| Net Income Continuous | -9,300 | -22,204 | -21,971 | -11,542 | -13,075 |
| Net Income | $-9,300 | $-22,204 | $-21,971 | $-11,542 | $-13,075 |
| EPS Basic Total Ops | -10.45 | -29.17 | -29.17 | -15.13 | -17.29 |
| EPS Basic Continuous Ops | -10.39 | -29.29 | -29.00 | -15.24 | -17.26 |
| EPS Diluted Total Ops | -10.45 | -29.17 | -29.17 | -15.13 | -17.29 |
| EPS Diluted Continuous Ops | -10.39 | -29.29 | -29.00 | -15.24 | -17.26 |
| EBITDA(a) | $-9,669 | $-22,207 | $-22,231 | $-11,733 | $-12,866 |